Women's Acceptability of Misoprostol Treatment for Incomplete Abortion by Midwives and Physicians - Secondary Outcome Analysis from a Randomized Controlled Equivalence Trial at District Level in Uganda

Amanda Cleeve, Josaphat Byamugisha, Kristina Gemzell-Danielsson, Nazarius Mbona Tumwesigye, Susan Atuhairwe, Elisabeth Faxelid, Marie Klingberg-Allvin, Amanda Cleeve, Josaphat Byamugisha, Kristina Gemzell-Danielsson, Nazarius Mbona Tumwesigye, Susan Atuhairwe, Elisabeth Faxelid, Marie Klingberg-Allvin

Abstract

Objective: This study aimed to assess women´s acceptability of diagnosis and treatment of incomplete abortion with misoprostol by midwives, compared with physicians.

Methods: This was an analysis of secondary outcomes from a multi-centre randomized controlled equivalence trial at district level in Uganda. Women with first trimester incomplete abortion were randomly allocated to clinical assessment and treatment with misoprostol by a physician or a midwife. The randomisation (1:1) was done in blocks of 12 and stratified for health care facility. Acceptability was measured in expectations and satisfaction at a follow up visit 14-28 days following treatment. Analysis of women's overall acceptability was done using a generalized linear mixed-effects model with an equivalence range of -4% to 4%. The study was not masked. The trial is registered at ClinicalTrials.org, NCT 01844024.

Results: From April 2013 to June 2014, 1108 women were assessed for eligibility of which 1010 were randomized (506 to midwife and 504 to physician). 953 women were successfully followed up and included in the acceptability analysis. 95% (904) of the participants found the treatment satisfactory and overall acceptability was found to be equivalent between the two study groups. Treatment failure, not feeling calm and safe following treatment, experiencing severe abdominal pain or heavy bleeding following treatment, were significantly associated with non-satisfaction. No serious adverse events were recorded.

Conclusions: Treatment of incomplete abortion with misoprostol by midwives and physician was highly, and equally, acceptable to women.

Trial registration: ClinicalTrials.gov NCT01844024.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Flowchart.
Fig 1. Flowchart.

References

    1. WHO, UNICEF, UNFPA, The World Bank, UNPD. Trends in maternal mortality: 1990 to 2013. Estimates by WHO, UNICEF, UNFPA, The World Bank and the United Nations Population Division. Geneva: World Health Organization, 2014.
    1. Faundes A. Unsafe abortion—the current global scenario. Best practice & research Clinical obstetrics & gynaecology. 2010;24(4):467–77.
    1. Shah IH, Ahman E, Ortayli N. Access to safe abortion: progress and challenges since the 1994 International Conference on Population and Development (ICPD). Contraception. 2014;90:39–48.
    1. Rasch V. Unsafe abortion and postabortion care—an overview. Acta obstetricia et gynecologica Scandinavica. 2011;90(7):692–700. 10.1111/j.1600-0412.2011.01165.x
    1. Mbonye AK, Asimwe JB, Kabarangira J, Nanda G, Orinda V. Emergency obstetric care as the priority intervention to reduce maternal mortality in Uganda. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2007;96(3):220–5.
    1. Hussain R. Unintended pregnancy and abortion in Uganda, In Brief, New York: Guttmacher Institute, 2013, No 2.
    1. East Central and Southern African Health Community (ECSA-HC). Task Shifting in Uganda: Case Study Washington, DC: Futures Group, Health Policy Initiative, Task Order 1: 2010.
    1. Paul M, Gemzell-Danielsson K, Kiggundu C, Namugenyi R, Klingberg-Allvin M. Barriers and facilitators in the provision of post-abortion care at district level in central Uganda—a qualitative study focusing on task sharing between physicians and midwives. BMC health services research. 2014;14:28 10.1186/1472-6963-14-28
    1. Nabudere H, Asiimwe D, Mijumbi R. Task shifting in maternal and child health care: an evidence brief for Uganda. International journal of technology assessment in health care. 2011;27(2):173–9. 10.1017/S0266462311000055
    1. Klingberg-Allvin M, Cleeve A, Atuhairwe S, Tumwesigye NM, Faxelid E, Byamugisha J, et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet. 2015; 385: 2392–98. 10.1016/S0140-6736(14)61935-8
    1. Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J, et al. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for postabortion care? Results from a randomised trial in Burkina Faso, West Africa. BJOG: an international journal of obstetrics and gynaecology. 2007;114(11):1368–75.
    1. Dabash R, Ramadan MC, Darwish E, Hassanein N, Blum J, Winikoff B. A randomized controlled trial of 400-mug sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2010;111(2):131–5.
    1. Shochet T, Diop A, Gaye A, Nayama M, Sall AB, Bukola F, et al. Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries. BMC pregnancy and childbirth. 2012;12:127 10.1186/1471-2393-12-127
    1. Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2007;99 Suppl 2:S160–7.
    1. Weeks A. Clarifying the role of misoprostol in obstetrics. African health sciences. 2001;1(2):52–4.
    1. Blandine T, Ouattara AZ, Coral A, Hassane C, Clotaire H, Dao B, et al. Sublingual [corrected] misoprostol as first-line care for incomplete abortion in Burkina Faso. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2012;119(2):166–9.
    1. Dah T, Akiode A, Awah P, Fetters T, Okoh M, Ujah I, et al. Introducing misoprostol for the treatment of incomplete abortion in Nigeria. African journal of reproductive health. 2011;15(4):42–50.
    1. Fawole AO, Diop A, Adeyanju AO, Aremu OT, Winikoff B. Misoprostol as first-line treatment for incomplete abortion at a secondary-level health facility in Nigeria. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2012;119(2):170–3.
    1. Shwekerela B, Kalumuna R, Kipingili R, Mashaka N, Westheimer E, Clark W, et al. Misoprostol for treatment of incomplete abortion at the regional hospital level: results from Tanzania. BJOG: an international journal of obstetrics and gynaecology. 2007;114(11):1363–7.
    1. Levesque JF, Harris MF, Russell G. Patient-centred access to health care: conceptualising access at the interface of health systems and populations. International journal for equity in health. 2013;12:18 10.1186/1475-9276-12-18
    1. Piaggio G, Elbourne DR, Pocock SJ, Evans SJ, Altman DG, Group C. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA: the journal of the American Medical Association. 2012;308(24):2594–604. 10.1001/jama.2012.87802
    1. Turner KL e. Medical abortion training guide, 2nd edn Chapel Hill, NC: 2010.
    1. Turner KL HA, eds. Woman-centered, comprehensive abortion care: trainer’s manual, 1st edn Chapel Hill, NC: 2004.
    1. Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2007;99 Suppl 2:S186–9.
    1. WHO. Safe Abortion: Technical and Policy Guidance for Health Systems. Geneva: World Health Organization, 2012.
    1. Gaye A, Diop A, Shochet T, Winikoff B. Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2014;126(3):223–6.
    1. Lehmann U, Van Damme W, Barten F, Sanders D. Task shifting: the answer to the human resources crisis in Africa? Human resources for health. 2009;7:49 10.1186/1478-4491-7-49
    1. WHO. Health worker roles in providing safe abortion care and post abortion contraception. Geneva: World Health Organization, 2015.
    1. Karki C, Pokharel H, Kushwaha A, Manandhar D, Bracken H, Winikoff B. Acceptability and feasibility of medical abortion in Nepal. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2009;106(1):39–42.
    1. Kopp Kallner H, Fiala C, Gemzell-Danielsson K. Assessment of significant factors affecting acceptability of home administration of misoprostol for medical abortion. Contraception. 2012;85(4):394–7. 10.1016/j.contraception.2011.08.009
    1. Paul M, Lyengar K, Essén B, Gemzell-Danielsson K, Lyengar S, Bring J, et al. Acceptability of home-assessment of outcome after medical abortion in a low-resource setting in Rajasthan, India: Secondary outcome analysis of A randomized controlled, non-inferiority trial. Plos One, in print, 2015.
    1. Uganda Ministry of Health. Reducing maternal and mortality from unsafe abortion in Uganda: Standards and guidelines. Kampala, Uganda: 2015.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit